Taxotere Lawsuits Increase To Over 1,000 Complaints Of Permanent Hair Loss From Chemotherapy Drug

   

Taxotere Lawsuits Maintain Breast Cancer Patients Suffered Permanent Hair Loss After Receiving The Texotere Chemotherapy Drug.

taxotere lawsuit taxotere hair-loss-lawsuit side effects hair lossThe number of Taxotere lawsuits have increased to over 1,000 filings. The lawsuits were filed by Women who contend they have experienced alopecia or permanent hair loss, after taking the Taxotere chemotherapy drug to treat breast cancer. The plaintiffs contend that Taxotere’s developer Sanofi-Aventis and its subsidiaries misled women and their doctors about Taxotere’s safety and failed to warn them about the permanent hair loss side-effect. (In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuits – MDL 2740)

“Our firm represents women in drug side-effect lawsuits such as Taxotere complaints where women are seeking legal recourse after suffering permanent hair loss allegedly due to the chemotherapy drug,” says Dr. François Blaudeau, founder of Southern Med Law, who is also a practicing attorney and an obstetrician/gynecologist.

If you have suffered permanent hair loss or other side effects after being prescribed the Taxotere chemotherapy drug to treat breast cancer, you can arrange for a free, no-obligation legal evaluation by calling Southern Med Law today at 205-547-5525 or visit www.southernmedlaw.com for more information and news on upcoming meetings and filings.

Taxotere alopecia complaints rose from 949 to 1,006 from April 17 to May 15, according to the U.S. Judicial Panel on Multidistrict Litigation’s (JPML) statistics report. The JPML established a multidistrict litigation (MDL) in October 2016 for all federally filed Taxotere hair loss lawsuits. The complaints are centralized in the Eastern District of Louisiana for coordinated pretrial proceedings. The JPML found the complaints had common allegations of Taxotere causing permanent hair loss and Sanofi-Aventis and its subsidiaries failing to adequately warn about the alopecia side effects. (In Re: Taxotere (Docetaxel) Products Liability Litigation – MDL 2740)

Taxotere (docetaxel) was approved by the U.S. Food and Drug Administration in 1996 to treat locally advanced or metastatic breast cancer in women whose previous chemotherapy treatments failed. Taxotere is part of a family of drugs known as Taxanes which are widely used as chemotherapy agents. Taxanes block cell growth by interfering with cell division. In addition to hair loss, patients taking Taxotere reported other side effects that include anemia, gastrointestinal bleeding, infections, nausea and vomiting, and skin reactions.
[accessdata.fda.gov/drugsatfda_docs/label/2010/020449s059lbl.pdf]

One Taxotere Hair Loss lawsuit added to the MDL was filed on behalf of a Louisiana woman who took the chemotherapy drug from June 2010 to July 2010 and allegedly suffered hair loss. According to the complaint, the woman also suffered mental anguish, severe and debilitating emotional distress, physical and mental pain as well as economic and non-economic damages. (Taxotere Lawsuit No. 2:2017cv05227, In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuit – MDL 2740)

The Louisiana woman’s complaint could be included in a proposed Taxotere class-action request pending before Judge Kurt D. Engelhardt, who is managing the Taxotere MDL. In April, three other Louisiana women asked Judge Engelhardt to grant class-action status to their Taxotere joint complaint filed under Louisiana’s Product Liability Act. The proposed class-action lawsuit would include all women from Louisiana who were given Taxotere during chemotherapy and have suffered from permanent hair loss and other injuries. (Taxotere Hair Loss Lawsuit Case No., 2:16-cv-17731; In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuits – MDL 2740)

About Southern Med Law And Filing A Taxotere Hair Loss Lawsuit

Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in Taxotere Hair Loss Lawsuits. They are not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success. To speak to one of the firm’s Taxotere Hair Loss lawsuit attorneys for a FREE Taxotere Hair Loss Lawsuit consultation please call 205-547-5525 or fill out the online form.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.